Assessment of Vascular Perfusion Kinetics Using Contrast‐enhanced Ultrasound for the Diagnosis of Prostatic Disease in Dogs
Authors:
- 13 March 2011
- journal article
- clinical trial
- Published by Wiley in Reproduction in Domestic Animals
- Vol. 46 (2) , 209-213
Abstract
Contents: Vascular perfusion was assessed in 10 dogs without prostatic abnormalities and 26 dogs with prostatic disease using contrast‐enhanced ultrasound. The time to reach peak contrast intensity (TTP) and peak perfusion intensity (PPI) were measured, and histological biopsies were collected from each dog. Biopsies confirmed normal prostate (n = 10), benign prostatic hyperplasia (n = 11), mixed benign pathology (n = 9), prostatitis (n = 1), prostatic malignancy [adenocarcinoma (n = 4); leiomyosarcoma (n = 1)]. In normal dogs, mean PPI was 16.8% ± 5.8 SD, and mean TTP was 33.6 ± 6.4 s. Benign conditions overall were not statistically different from normal dogs (p > 0.05); for benign prostatic hyperplasia, mean PPI was 16.9 ± 3.8%, and mean TTP was 26.2 ± 5.8 s; for mixed benign pathology mean PPI was 14.8 ± 7.8%, and mean TTP was 31.9 ± 9.7 s; for prostatitis, PPI was 14.2%, and TTP was 25.9 s. The malignant conditions overall had perfusion values that differed from the normal dogs (p < 0.05), although evaluation of the data for individual malignancies did not demonstrate a consistent trend; for adenocarcinomas, the PPI was numerically higher with a mean of 23.7 ± 1.9%, and the mean TTP was 26.9 ± 4.8 s, whilst for the dog with leiomyosarcoma values were numerically lower with a PPI of 14.1% and TTP of 41.3 s. Contrast‐enhanced ultrasound appears to offer some ability to document differences in perfusion that may differentiate between malignant and benign lesions, although studies with larger numbers of animals are required to confirm this contention.Keywords
This publication has 27 references indexed in Scilit:
- RELATIONSHIP BETWEEN PROSTATOMEGALY, PROSTATIC MINERALIZATION, AND CYTOLOGIC DIAGNOSISVeterinary Radiology & Ultrasound, 2009
- Review of clinical characteristics and applications of contrast-enhanced ultrasonography in dogsJournal of the American Veterinary Medical Association, 2009
- Tumor targeting and SPECT imaging properties of an 111In-labeled galectin-3 binding peptide in prostate carcinomaNuclear Medicine and Biology, 2009
- La tomografía por emisión de positrones (pet) y pet-tac en riñón, vías urinarias y próstata: actualizaciónActas Urológicas Españolas, 2009
- Prostate cancer imagingActa Radiologica, 2008
- [Prostate cancer: synopsis of the American Urological Association (AUA) 2006].Annales d'Urologie, 2006
- Diagnostic Value of Systematic Biopsy Methods in the Investigation of Prostate Cancer: A Systematic ReviewJournal of Urology, 2006
- The Value of Dynamic Contrast Enhanced Power Doppler Ultrasound Imaging in the Localization of Prostate CancerEuropean Urology, 2003
- OPTIMAL PREDICTORS OF PROSTATE CANCER ON REPEAT PROSTATE BIOPSY: A PROSPECTIVE STUDY OF 1,051 MENJournal of Urology, 2000
- Ultrasonographic estimation of prostate size in normal dogs and relationship to bodyweight and ageJournal of Small Animal Practice, 1999